When steroids are not enough in immune-related hepatitis: current clinical challenges discussed on the basis of a case report
10.1136/jitc-2021-002337
March 25, 2021
Commentary/Editorials
Section Edited by Christian M. Capitini, MD
Extending the conversation over the immune-related hepatotoxicity: author response to Dr. Gauci et al
10.1136/jitc-2021-002391
March 18, 2021
Letter to the editor: Hypoxia kinetics and histology in combined radiotherapy and oxidative phosphorylation inhibition effects on antitumor immunity
10.1136/jitc-2020-001793
March 11, 2021
Perspectives on COVID-19 and cancer immunotherapy: a review series
10.1136/jitc-2021-002489
March 9, 2021
Real-world insights on preferred treatments for steroid-refractory immune checkpoint inhibitor-induced pneumonitis
10.1136/jitc-2020-002252
February 18, 2021
Immune checkpoint inhibitor-related hypogonadism and infertility: a neglected issue in immuno-oncology
10.1136/jitc-2020-002220
February 15, 2021
Letter to the editor: Checking the pulse of adoptive cell therapy for solid tumors. Thoughts from the abstracts submitted to the 35th Annual Meeting of the Society for the Immunotherapy of Cancer (SITC 2020)
10.1136/jitc-2020-002216
January 8, 2021
Complement controls the immune synapse and tumors control complement
10.1136/jitc-2020-001712
December 15, 2020
Management of immune checkpoint therapy for patients with cancer in the face of COVID-19
10.1136/jitc-2020-001593
December 10, 2020
Microbiome-derived metabolome as a potential predictor of response to cancer immunotherapy
10.1136/jitc-2020-001383
October 30, 2020